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Abstract
As in much of the world, mental health law in Israel has evolved over the past half-century toward greater
protection of patients’ liberty and an increased emphasis on due process. Part of that process in Israel involved
taking decisions about prolonged involuntary hospitalization out of the hands of treating psychiatrists and turning
them over to independent review panels. Argo and colleagues examined outcomes of discharge decisions made
by these panels compared with treating psychiatrists. In this brief commentary, we describe related trends in
mental health law in other countries, especially the U.S., consider countervailing perspectives on the role of review
panels, and suggest how the Argo et al. study might be followed up with additional research.
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Background
Argo and colleagues retrospectively examined outcomes
of psychiatric hospital discharge decisions made by
district psychiatric committees (DPCs) compared to
treating psychiatrists (TPs), based on data from the
Ministry of Health’s National Psychiatric Hospitalization
Registry. [1] They concluded that patients discharged by
DPCs (which have a magistrate-level attorney as chair
and two psychiatrists as members) had a higher prob-
ability of readmission than patients discharged by TPs.
Based on their data, they suggest that judicial decisions
are driven by faulty assumptions that patients will fare
better in the community than in the hospital.
A number of authors have described the evolution of
Israel’s mental health law and its shift over the past half-
century towards greater emphasis on patient liberty and
autonomy, and on community treatment [2–4]. In this
brief commentary, we describe similar trends in other
countries, especially the U.S., consider countervailing
perspectives, and suggest how Argo and colleagues’
study might lead to additional research.
Evolution of civil commitment law
The development of Israel’s civil commitment law
mirrors trends seen elsewhere, including in the U.S.
From the earliest days of psychiatric hospitalization in
the U.S., admission and discharge decisions were in the
hands of physicians, who determined whether patients
needed hospital treatment. It was, in essence, a
beneficence-based approach. The introduction of invol-
untary commitment laws in the early nineteenth-century
formalized that process, but it was not until later in the
century that most commitment decisions received
routine judicial review. In the mid-twentieth century,
however, questions about the benefits of hospitalization,
arguments for community-based treatment (facilitated
by the emergence of novel psychopharmacologic treat-
ments), greater respect for the civil liberties of people
with mental illness, and a desire for more cost-effective
care precipitated changes in the process [5].
By the end of the 1970s, involuntary commitment
laws in every state in the U.S. were revised. Commit-
ment was limited to persons who were likely to be a
danger to themselves or others, or unable to care for
themselves. Patients seeking to challenge their invol-
untary hospitalization were afforded greater protec-
tions, often drawn from procedures for criminal
defendants, including rights to notice of the hearing,
to testify and call witnesses, and to appeal adverse
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findings. Other countries - including countries as di-
verse as Canada, Germany, Taiwan, and of course
Israel - followed suit [6]. The reforms of the 1970s
remain largely in place around the world today.
However, there are often substantial variations across
jurisdictions, and Israeli law differs from statutes in the
U.S. in a number of ways. In Israel, involuntary
hospitalization is predicated on the patient being psych-
otic [7], which is not a requirement in the U.S. Whereas
the majority of members of Israel’s District Psychiatric
Committees, which review requests for extended com-
mitment, are psychiatrists, in the U.S. similar requests
are reviewed by judges or hearing officers, typically with
no clinical training. In addition, mean length of psychi-
atric hospitalization generally has been longer in Israel
(36 days [8] vs. 7 to 13 days in the U.S. [9, 10]), where
facilities have not been subject to the same degree of
vigorous utilization management as U.S. hospitals.
Notwithstanding the differences, concerns similar to
the ones expressed by Argo et al. about the conse-
quences of someone other than the treating psychiatrist
making discharge decisions have been raised by psychia-
trists in the U.S. and other countries. Opponents of U.S.
civil commitment reforms in the last century argued that
reducing the reliance of judges on the opinions of
treating psychiatrists—a predicted consequence of the
embrace of dangerousness standards for involuntary
commitment—would deprive patients of needed treat-
ment. However, taken in the aggregate, studies have
failed to demonstrate consistent changes in the rates of
commitment or the characteristics of committed pa-
tients, or evidence that patients in need of immediate
hospitalization were being turned away, as direct conse-
quences of changes in the laws [5].
We think that it is fair to say that most psychiatrists in
the U.S., Canada, Australia, and Western Europe, where
decisions about extending involuntary hospitalization
are in judicial or quasi-judicial hands, have reconciled
themselves to the process. Indeed, many clinicians may
have come to recognize advantages to a court-driven
process, such as maintaining an alliance with the patient
when someone else makes the discharge decision [11].
Perhaps surprisingly, studies have suggested that rather
than strictly applying dangerousness standards to their
release decisions, judges may actually follow more of a
parens patriae approach, taking into account patients’
treatment needs, the availability of community-based
services [12], and the impact on families of premature
discharges [13]. Moreover, even in dangerousness-based
determinations, judges frequently defer to medical
recommendations [12, 14].
One other trend worth noting is the development of
outpatient civil commitment, sometimes referred to as
Assisted Outpatient Treatment (AOT) or, in the British
Commonwealth, Community Treatment Orders (CTO).
New York’s statute, passed in 1999, is typical of the
newer generation of outpatient commitment laws in
American states. Usually applied to patients at the time
of hospital discharge, it focuses on patients who have re-
peatedly failed to adhere to treatment, resulting in
hospitalization or arrest. After a court hearing, patients
may be required to receive regular psychiatric care, take
medications, participate in rehabilitation programs, and
avoid substance use [15]. Outpatient commitment laws
allow patients greater liberty than inpatient commit-
ment, while still requiring compliance with treatment,
balancing liberty and beneficence. Currently, 45 states and
the District of Columbia have such statutes, which studies
suggest are associated with increased access to care,
improved adherence to treatment, reduced costs, fewer
hospitalizations, and decreased risk of arrest [16–18].
Autonomy, beneficence and involuntary commitment
Changes to commitment laws around the world have
been driven by desires to restrict the grounds for
deprivation of liberty and guarantee independent review
of such deprivations when they occur. In the U.S., these
reforms were based on new understandings of constitu-
tional limitations on state power and requirements for
due process [5]; elsewhere, they often have been based
on notions of intrinsic human rights to liberty and
autonomy [19]. The current generation of involuntary
commitment laws typically requires periodic reviews of
the status of committed patients, which focus on
whether commitment criteria continue to be met, and
places the decision in the hands of judges or panels
exercising quasi-judicial functions. It seems evident that
contemporary civil commitment processes are designed
to protect fundamental rights to liberty and autonomy,
even at the risk of less effective treatment, more rapid
decompensation, and higher rates of re-hospitalization.
In these processes, rights are given precedence over
treatment considerations: beneficence is subordinated
to liberty.
How great are the costs of taking these discharge deci-
sions out of the hands of treating psychiatrists, a nearly
universal characteristic of modern laws? Civil liberties
advocates might note that Argo et al.’s data suggest the
cost is not particularly great. Patients discharged by
DPCs remained in the community for a median of
175 days compared to 211 days for the TP group, a
difference of 36 days. But patients discharged by TPs
were kept more than twice as long in the hospital
(76 days vs. 30 days), a difference of 46 days, not only
wiping out the advantage of time in the community for
TP decisions, but apparently reversing it. Moreover, the
differences in “failure” rate between the groups, as de-
fined by the researchers (see below), were decidedly
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modest. From this perspective, DPCs not only offer a
check on the unbridled discretion of treating psychia-
trists that protects patients’ rights to liberty, they do so
at no cost (and perhaps some benefit) to length of time
in the community.
Moving forward with a research agenda
Argo and colleagues found statistically significant
differences in rates of readmission between DPC and TP
discharged patients, including an adjusted 30% lower
probability of “failure” (defined as readmission in less than
30 days, involuntary civil readmission in less than 180 days,
and involuntary readmission under court order in less
than one year) in the TP group. However, the absolute dif-
ference in readmission rates, though statistically signifi-
cant, was somewhat modest (4.6%, 7%, and 6.4% within
30, 180 and 365 days, respectively) and varied markedly
among groups by age, sex, diagnosis, and duration of
index hospitalization. Nor do these data address the possi-
bility that discharged patients do better in other ways (e.g.,
maintaining housing or employment). Thus, future com-
parisons of discharge decisions by treaters and review
panels or judges may benefit from additional outcome
measures, such as measures of symptoms, rates of adher-
ence to aftercare and medications, and social outcomes,
and from the use of validated rating scales. Although
readmission rates may be a valid quality measure of psy-
chiatric hospitalization, other methods may provide a
finer-grained basis for comparison [20].
Further elucidating the differences between DPC and
TP decision processes (and their equivalents in other
countries) would also be informative. What additional
factors associated with good outcomes in the community
(e.g., availability of community services, previous en-
gagement in outpatient treatment, presence of support-
ive family members and friends) may help to explain
disagreement between DPCs and TPs? Future investiga-
tors might also explore the extent to which TPs seek
renewed involuntary commitment because of liability
concerns, not a belief that patients continue to meet
commitment criteria or would benefit from prolonged
hospital stays. That is, since DPCs are immunized from
liability whereas TPs are not [21], are some cases taken
to the committee knowing that patients will be released,
because the treating psychiatrist is reluctant to assume
the risk of authorizing discharge? Pertinent to the Israeli
context, in a recent survey of 213 Israeli psychiatry
residents and psychiatrists, 62% reported practicing
defensive psychiatry, and 54% specifically acknowledged
advising unwarranted hospitalization of suicidal pa-
tients [22]. To the extent that treating psychiatrists
themselves would discharge patients in the absence of
a DPC mechanism, inclusion of such cases confounds
examination of instances in which their decisions
would differ.
Conclusions
Argo and colleagues provide a useful starting point for
examining the effects of policies relegating decisions
about prolonged involuntary hospitalization to quasi-
judicial panels like the DPCs. Although the mandate of
such review bodies is not to maximize patients’ clinical
benefit—liberty trumps beneficence under most contem-
porary statutes—exploration in other jurisdictions of the
consequences of their decisions is warranted. Perhaps, as
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